EIF4A inhibition targets bioenergetic homeostasis in AML MOLM-14 cells in vitro and in vivo and synergizes with cytarabine and venetoclaxKatie Fooks(Jewish General Hospital), François Mercier(Jewish General Hospital)Journal of Experimental & Clinical Cancer ResearchDecember 9, 202210.1186/s13046-022-02542-8Cited by 35SaveCiteExport RISWatch citationsRelated PapersCommon clonal origin of chronic myelomonocytic leukemia and B-cell acute lymphoblastic leukemia in a patient with a germline <i>CHEK2</i> variant|Molecular Case Studies|2021|8EIF4A inhibition targets bioenergetic homeostasis in AML and synergizes with cytarabine and venetoclax|Research Square|2022|0